IgG4-related disease (IgG4 - RD) and autoimmune pancreatitis
Immunoglobulin G4 (IgG4)-related systemic disease (IgG4-RSD) is a systemic entity associated with autoimmune pancreatitis (AIP)
- AIP is a distinct type of chronic pancreatitis and is characterized by abundant infiltration of Immunoglobulin G4 (IgG4)-positive plasma cells and associated fibrosis that lead to organ dysfunction
- there are three recognized patterns of AIP
- diffuse, focal, and multifocal
- patients with AIP typically present with jaundice or abdominal discomfort, severe abdominal pain, or acute pancreatitis
- there are three recognized patterns of AIP
- other organ involvements take the form of sclerosing cholangitis, sclerosing cholecystitis, sclerosing sialadenitis, retroperitoneal fibrosis, and interstitial nephritis
- lung diseases related to IgG4 have been described to occur with or without other organ involvement
- these diseases include interstitial lung disease (ILD), pulmonary inflammatory pseudotumour, and lymphomatoid granulomatosis
Notes (3):
- autoimmune pancreatitis can present as acute or chronic pancreatitis
- most common clinical presentation is painless jaundice
- more commonly occurs in patients over age 60 with a three to one male predominance
- serologic marker for autoimmune pancreatitis is an increased concentration of circulating IgG4
- most often responsive to steroid treatment or alternatively to other immune modulators in steroid resistant cases
References:
- Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539-51.
- Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:57-66.
- Hines O J, Pandol S J. Management of chronic pancreatitis BMJ 2024; 384 :e070920 doi:10.1136/bmj-2023-070920
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.